or Try an Advanced Search...

    Technical Analysis for EVOK - Evoke Pharma, Inc.

    Grade Last Price % Change Price Change
    F 4.55 -0.21% -0.01
    EVOK closed down 2.98 percent on Wednesday, November 20, 2024, on 2 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical EVOK trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.21%
    NR7 Range Contraction -0.21%
    Narrow Range Bar Range Contraction -0.21%
    Inside Day Range Contraction -0.21%
    Wide Bands Range Expansion -0.21%
    Oversold Stochastic Weakness -0.21%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.19%
    1,2,3 Pullback Bullish Bullish Swing Setup -3.19%
    Outside Day Range Expansion -3.19%
    Wide Bands Range Expansion -3.19%
    Older End-of-Day Signals for EVOK ...

       Recent Intraday Alerts

    Alert Time
    Down 1% about 1 hour ago
    Possible NR7 about 3 hours ago
    Possible Inside Day about 3 hours ago
    60 Minute Opening Range Breakout about 5 hours ago
    Possible NR7 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    EVOK Chart by TradingView
    Basic chart:

    Profile

    Evoke Pharma, Inc., a specialty pharmaceutical company, engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded in 2007 and is headquartered in San Diego, California.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Pharmaceutical Disease Diabetes Gastrointestinal Gastroenterology Diabetes Mellitus Chloroarenes Antiemetics Benzamides Gastrointestinal Disorders Gastroparesis Metoclopramide Nasal Spray Prolactin Releasers

    Is EVOK a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 10 Evoke Pharma Third Quarter 2024 Earnings: Misses Expectations
    Nov 8 Evoke Pharma GAAP EPS of -$0.94, revenue of $2.65M
    Nov 7 Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results
    Nov 4 Evoke Pharma, Inc.'s (NASDAQ:EVOK) Shift From Loss To Profit
    Oct 29 Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
    Oct 28 Evoke Pharma Shares Soar on Positive Data for Gimoti Nasal Treatment in Diabetic Gastroparesis
    Oct 28 Evoke stock rockets 90% on study of Gimoti in GLP-1 users
    Oct 28 Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI®
    Oct 23 Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting
    Oct 22 Evoke Pharma Announces the Appointment of Ben Smeal to the Board of Directors
    See more EVOK news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.4
    52 Week Low 3.54
    Average Volume 487,396
    200-Day Moving Average 5.97
    50-Day Moving Average 5.14
    20-Day Moving Average 5.39
    10-Day Moving Average 4.85
    Average True Range 0.61
    RSI (14) 41.18
    ADX 29.14
    +DI 30.19
    -DI 23.99
    Chandelier Exit (Long, 3 ATRs) 10.49
    Chandelier Exit (Short, 3 ATRs) 5.86
    Upper Bollinger Bands 6.89
    Lower Bollinger Band 3.89
    Percent B (%b) 0.22
    BandWidth 55.57
    MACD Line -0.23
    MACD Signal Line -0.08
    MACD Histogram -0.1458
    Fundamentals Value
    Market Cap 15.24 Million
    Num Shares 3.34 Million
    EPS -2.27
    Price-to-Earnings (P/E) Ratio -2.01
    Price-to-Sales 0.58
    Price-to-Book 1.79
    PEG Ratio -0.10
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.85
    Resistance 3 (R3) 4.87 4.78 4.81
    Resistance 2 (R2) 4.78 4.71 4.78 4.79
    Resistance 1 (R1) 4.67 4.66 4.63 4.66 4.77
    Pivot Point 4.59 4.59 4.57 4.58 4.59
    Support 1 (S1) 4.48 4.51 4.43 4.46 4.35
    Support 2 (S2) 4.39 4.47 4.39 4.33
    Support 3 (S3) 4.28 4.39 4.32
    Support 4 (S4) 4.27